US2015099797A1PendingUtilityA1
Oligonucleotide compositions with enhanced efficiency
Est. expiryFeb 1, 2022(expired)· nominal 20-yr term from priority
A61P 37/02A61P 9/00A61P 43/00A61P 27/02A61P 31/12A61P 31/18A61P 29/00A61P 35/00A61P 31/20A61P 1/04A61P 17/06C12N 2310/315C12N 2320/31C12Y 301/03048C12N 2320/50C12N 15/1137C12N 15/113A61K 31/713C12N 2310/111C12N 2330/30C12N 15/111C12N 15/1135C12N 2310/11C12Y 207/11022C12N 2310/14C12N 2320/30C12N 2320/11
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The oligonucleotide compositions of the present invention make use of combinations of oligonucleotides. In one aspect, the invention features an oligonucleotide composition including at least 2 different oligonucleotides targeted to a target gene. This invention also provides methods of inhibiting protein synthesis in a cell and methods of identifying oligonucleotide compositions that inhibit synthesis of a protein in a cell.
Claims
exact text as granted — not AI-modified1 - 29 . (canceled)
30 . An oligonucleotide composition comprising at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene.
31 . A method of inhibiting protein synthesis in a cell comprising contacting the cell with at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene.
32 . A method of identifying function of a gene encoding a protein comprising: contacting the cell with at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene and assaying for a change in a detectable phenotype in the cell resulting from the inhibition of protein expression, to thereby determine the function of a gene.
33 . A method of making an oligonucleotide composition comprising: combining at least three different double-stranded RNA oligonucleotides targeted to at least three different nucleotide sequences within a target gene wherein, the individual oligonucleotides are not separately tested for their ability to inhibit protein synthesis prior to their incorporation into the composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.